Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	71.87	127.57	133.52	176.77	253.03
Short-Term Investments	66.51	24.93	71.68	247.2	297.97
Cash & Short-Term Investments	138.38	152.5	205.2	423.96	551
Cash Growth	-9.26%	-25.68%	-51.60%	-23.05%	45.66%
Other Current Assets	10.29	8.31	8.32	20.47	7.11
Total Current Assets	148.68	160.81	213.52	444.44	558.1
Net Property, Plant & Equipment	65.22	135.27	145.59	159.4	161.78
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2
Goodwill	-	-	140.63	140.63	140.63
Long-Term Investments	-	-	-	10.05	195.88
Other Long-Term Assets	3.17	5.12	6.37	9.01	13.82
Total Assets	276.26	360.39	565.3	822.72	1,129
Accounts Payable	1.67	5.21	4.11	2.86	2.22
Accrued Expenses	21.92	27.69	47.18	40.91	31.48
Current Portion of Leases	14.94	12.53	13.2	12.39	9.16
Other Current Liabilities	40.2	-	-	55.35	56.38
Total Current Liabilities	78.73	45.43	64.49	111.5	99.24
Long-Term Leases	63.92	81.66	90.9	95.86	101.78
Other Long-Term Liabilities	113.36	123.42	122.41	116.04	199.89
Total Long-Term Liabilities	177.28	205.08	213.31	211.9	301.67
Total Liabilities	256.01	250.52	277.79	323.41	400.91
Common Stock	0.03	0.02	0.02	0.02	0.02
Additional Paid-in Capital	2,010	1,855	1,626	1,558	1,515
Accumulated Other Comprehensive Income	0.03	0.01	-0.06	-4.33	-1.37
Retained Earnings	-1,849	-1,605	-1,338	-1,055	-785.36
Total Common Shareholders' Equity	160.88	250.5	287.51	499.32	728.5
Shareholders' Equity	160.88	250.5	287.51	499.32	728.5
Total Liabilities & Equity	416.89	501.02	565.3	822.72	1,129
Total Debt	78.86	94.2	104.1	108.25	110.94
Net Cash (Debt)	59.52	58.3	101.1	315.71	440.05
Net Cash Growth	2.09%	-42.33%	-67.98%	-28.26%	43.64%
Net Cash Per Share	0.23	0.25	0.52	1.68	2.64
Book Value	160.88	250.5	287.51	499.32	728.5
Book Value Per Share	0.64	1.08	1.48	2.65	4.38
Tangible Book Value	101.69	191.31	87.68	299.49	528.68
Tangible Book Value Per Share	0.40	0.83	0.45	1.59	3.18

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q